Role of Notch-1 and E-Cadherin in the Differential Response to Calcium in Culturing Normal versus Malignant Prostate Cells
Open Access
- 15 October 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (20) , 9269-9279
- https://doi.org/10.1158/0008-5472.can-04-3989
Abstract
A panel of expression markers was validated and used to document that, when radical prostatectomy specimens are cultured in low (i.e., 400 μmol/L, Notch-1 conformationally is no longer constitutively active but requires cell-cell contact for reciprocal binding of Jagged-1 ligands and Notch-1 receptors between adjacent transit-amplifying cells to activate their survival signaling. Such cell-cell contact is enhanced by the elevated Ca2+ inducing an E-cadherin conformation allowing homotypic interaction between transit-amplifying cells. Such Ca2+-dependent, E-cadherin-mediated interaction, however, results in cell aggregation, stratification, and inhibition of proliferation of transit-amplifying cells via contact inhibition–induced up-regulation of p27/kip1 protein. In addition, transit-amplifying cells not contacting other cells undergo squamous differentiation into cornified (i.e., 1% SDS insoluble) envelopes and death in the elevated Ca2+ medium. Stratification and contact inhibition induced by elevated Ca2+ are dependent on E-cadherin–mediated homotypic interaction between transit-amplifying cells as shown by their prevention in the presence of a cell-impermanent, E-cadherin neutralizing antibody. In contrast to growth inhibition of normal transit-amplifying cells, supplementation of low-Ca2+-SFD medium with 10% FCS and raising the Ca2+ to >600 μmol/L stimulates the growth of all prostate cancer cell lines tested. Additional results document that, at physiologic levels of Ca2+ (i.e., >600 μmol/L), prostatic cancer cells are not contact inhibited by E-cadherin interactions and Notch-1 signaling is no longer required for survival but instead becomes one of multiple signaling pathways for proliferation of prostatic cancer cells. These characteristic changes are consistent with prostate cancer cells' ability to metastasize to bone, a site of high-Ca2+ levels.Keywords
This publication has 38 references indexed in Scilit:
- Consequences of Notch-mediated induction of Jagged1Experimental Cell Research, 2004
- Molecular characterization of human prostate carcinoma cell linesThe Prostate, 2003
- Design and Synthesis of Highly Potent Benzodiazepine γ-Secretase Inhibitors: Preparation of (2S,3R)-3-(3,4- Difluorophenyl)-2-(4-fluorophenyl)-4- hydroxy-N-((3S)-1-methyl-2-oxo-5- phenyl-2,3-dihydro-1H-benzo[e][1,4]- diazepin-3-yl)butyramide by Use of an Asymmetric Ireland−Claisen RearrangementJournal of Medicinal Chemistry, 2003
- Intermediate basal cells of the prostate: In vitro and in vivo characterizationThe Prostate, 2003
- HES and HERP families: Multiple effectors of the notch signaling pathwayJournal of Cellular Physiology, 2003
- Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer modelsThe Prostate, 2003
- A novel human cancer culture model for the study of prostate cancerOncogene, 2001
- L-685,458, an Aspartyl Protease Transition State Mimic, Is a Potent Inhibitor of Amyloid β-Protein Precursor γ-Secretase ActivityBiochemistry, 2000
- Chromosomal abnormalities in HPV-16-immortalized oral epithelial cellsCarcinogenesis: Integrative Cancer Research, 1996
- In VitroStudies of Human Prostatic Epithelial Cells: Attempts to Identify Distinguishing Features of Malignant CellsGrowth Factors, 1989